Item 2. Properties
Item 2. PROPERTIES
We lease three facilities in Gaithersburg, Maryland, Novavax AB leases a facility in Uppsala, Sweden and Novavax CZ owns a facility in Bohumil, Czech Republic. A summary of our current facilities is set forth below. Although we believe that our facilities are suitable and adequate for our present needs, the Company’s management continues to review and assess real property requirements that may be necessary to address our current business plan.
Property
Location Approximate
Square Footage Brief Property
Description
700QO Gaithersburg, MD 170,000 Manufacturing, research and development facility and offices
21FF Gaithersburg, MD 53,000 Research and development facility and offices
22FF Gaithersburg, MD 40,000 Executive, administrative, clinical and regulatory offices
Uppsala, Sweden 37,300 Adjuvant manufacturing and research and development facility and offices
Bohumil, Czech Republic 138,400 Manufacturing facility and offices
Total square footage 438,700
Item 3. LEGAL PROCEEDINGS
We currently have no material pending legal proceedings.
Item 4. MINE SAFETY DISCLOSURES
Not applicable.
50
Table of C onten ts
PART II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.